- ISIN
- US4161962026
- CUSIP
- 416196202
- IPO Date
- Nov 4, 1993
Highlights
- Market Cap
- $17.87M
- Enterprise Value
- $39.31M
- EPS (TTM)
- -$0.14
- Total Revenue (TTM)
- $155.27M
- Gross Profit (TTM)
- $55.70M
- EBITDA (TTM)
- $4.29M
- Year Range
- $2.22 - $4.48
- ROA (TTM)
- -1.16%
- ROE (TTM)
- -5.21%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HHS Performance Chart
Harte-Hanks, Inc. Common Stock (HHS) is down 19.9% since the beginning of the year. At $2 per share, HHS is trading 46.2% below its 52-week high of $4. Investors who bought $1,000 worth of HHS shares 5 years ago would now be looking at an investment worth $374.
Loading charts...
Returns By Period
Harte-Hanks, Inc. Common Stock (HHS) has returned -19.93% so far this year and -37.08% over the past 12 months. Over the last ten years, HHS has returned -16.98% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Harte-Hanks, Inc. Common Stock
- 1D
- 0.42%
- 1M
- -8.02%
- YTD
- -19.93%
- 6M
- -27.84%
- 1Y
- -37.08%
- 3Y*
- -24.23%
- 5Y*
- -17.87%
- 10Y*
- -16.98%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
HHS Monthly Returns History
Based on dividend-adjusted daily data since Nov 4, 1993, HHS's average daily return is +0.02%, while the average monthly return is +0.22%. At this rate, an investment would double in approximately 26.3 years.
Historically, 51% of months were positive and 49% were negative. The best month was Jun 2016 with a return of +60.8%, while the worst month was Mar 2020 at -47.3%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.
On a daily basis, HHS closed higher 46% of trading days. The best single day was Jun 10, 2016 with a return of +58.4%, while the worst single day was Jul 14, 2020 at -32.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.66% | -9.25% | -17.44% | 21.98% | -9.71% | -3.60% | -19.93% | ||||||
| 2025 | 4.66% | -5.19% | -6.07% | 4.17% | -9.00% | -12.53% | -14.32% | 5.57% | 3.06% | -16.17% | 21.23% | -20.16% | -41.55% |
| 2024 | 13.99% | -0.65% | -2.73% | -5.21% | 3.39% | 10.78% | 3.94% | -10.78% | -1.20% | -4.44% | -17.86% | -11.82% | -24.15% |
| 2023 | 6.67% | -14.84% | -11.39% | -10.31% | -33.53% | -2.32% | 4.93% | 12.35% | 0.77% | 0.31% | 4.29% | -0.29% | -41.92% |
| 2022 | -12.37% | -1.80% | 15.75% | -2.77% | 23.10% | 40.62% | 2.04% | 17.69% | -27.12% | 2.87% | -12.47% | 16.43% | 53.82% |
| 2021 | 3.82% | 22.59% | 24.29% | 19.77% | 26.68% | -12.12% | 8.62% | 4.76% | 18.18% | -7.05% | 11.81% | -6.25% | 176.36% |
Benchmark Metrics
Harte-Hanks, Inc. Common Stock has an annualized alpha of -3.97%, beta of 0.80, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since November 04, 1993.
- This stock participated in 96.12% of S&P 500 Index downside but only 30.04% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -3.97%
- Beta
- 0.80
- R²
- 0.10
- Upside Capture
- 30.04%
- Downside Capture
- 96.12%
Return for Risk
Risk / Return Rank
HHS ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Harte-Hanks, Inc. Common Stock (HHS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HHS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.73 | ||
| Sortino ratioReturn per unit of downside risk | -3.64 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.37 | -0.48 |
| Calmar ratioReturn relative to maximum drawdown | -0.87 | 2.78 | -3.65 |
| Martin ratioReturn relative to average drawdown | -1.54 | 12.44 | -13.97 |
Dividends
Dividend History
Harte-Hanks, Inc. Common Stock provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 | $3.40 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.63% | 10.49% |
Monthly Dividends
The table displays the monthly dividend distributions for Harte-Hanks, Inc. Common Stock. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Harte-Hanks, Inc. Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Harte-Hanks, Inc. Common Stock was 99.44%, occurring on Apr 2, 2020. The portfolio has not yet recovered.
The current Harte-Hanks, Inc. Common Stock drawdown is 98.86%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -99.44%Apr 2020 | 14y 9mo | — | 21y 7dJun 2005 - now |
1999 bear market1999 | -31.85%Nov 1999 | 7mo 21d | 2y 2mo | 2y 10moMar 1999 - Jan 2002 |
1998 bear market1998 | -29.53%Oct 1998 | 2mo 18d | 1mo 12d | 4moJul 1998 - Nov 1998 |
Dot-com crash2000–2002 | -27.36%Jul 2002 | 2mo 6d | 1y 5mo | 1y 7moMay 2002 - Dec 2003 |
1994 correction1994 | -16.47%Dec 1994 | 10mo 14d | 4mo 7d | 1y 2moFeb 1994 - Apr 1995 |
Drawdown Indicators
| HHS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.44% | -56.78% | -42.66% |
Max Drawdown (1Y)Largest decline over 1 year | -42.96% | -9.10% | -33.86% |
Max Drawdown (3Y)Largest decline over 3 years | -74.18% | -18.90% | -55.28% |
Max Drawdown (5Y)Largest decline over 5 years | -87.14% | -25.43% | -61.71% |
Max Drawdown (10Y)Largest decline over 10 years | -93.94% | -33.92% | -60.02% |
Current DrawdownCurrent decline from peak | -98.86% | -1.80% | -97.06% |
Average DrawdownAverage peak-to-trough decline | -51.58% | -10.71% | -40.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.18% | 2.03% | +22.15% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Harte-Hanks, Inc. Common Stock over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Harte-Hanks, Inc. Common Stock is priced in the market compared to other companies in the undefined industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HHS relative to other companies in the undefined industry. Currently, HHS has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HHS in comparison with other companies in the undefined industry. Currently, HHS has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HHS
Add Harte-Hanks, Inc. Common Stock to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HHS